These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

174 related items for PubMed ID: 36374935

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Circulating Bile Acid Profiles: A Need for Further Examination.
    Qi L, Tian Y, Chen Y.
    J Clin Endocrinol Metab; 2021 Oct 21; 106(11):3093-3112. PubMed ID: 34279029
    [Abstract] [Full Text] [Related]

  • 5. Fasting serum bile acids concentration is associated with insulin resistance independently of diabetes status.
    Lee SG, Lee YH, Choi E, Cho Y, Kim JH.
    Clin Chem Lab Med; 2019 Jul 26; 57(8):1218-1228. PubMed ID: 30964746
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Bile acids profile, histopathological indices and genetic variants for non-alcoholic fatty liver disease progression.
    Nimer N, Choucair I, Wang Z, Nemet I, Li L, Gukasyan J, Weeks TL, Alkhouri N, Zein N, Tang WHW, Fischbach MA, Brown JM, Allayee H, Dasarathy S, Gogonea V, Hazen SL.
    Metabolism; 2021 Mar 26; 116():154457. PubMed ID: 33275980
    [Abstract] [Full Text] [Related]

  • 9. The Presence and Severity of Nonalcoholic Steatohepatitis Is Associated with Specific Changes in Circulating Bile Acids.
    Gottlieb A, Bechmann L, Canbay A.
    Ann Hepatol; 2018 Mar 26; 17(3):340-341. PubMed ID: 29735794
    [Abstract] [Full Text] [Related]

  • 10. The presence and severity of nonalcoholic steatohepatitis is associated with specific changes in circulating bile acids.
    Puri P, Daita K, Joyce A, Mirshahi F, Santhekadur PK, Cazanave S, Luketic VA, Siddiqui MS, Boyett S, Min HK, Kumar DP, Kohli R, Zhou H, Hylemon PB, Contos MJ, Idowu M, Sanyal AJ.
    Hepatology; 2018 Feb 26; 67(2):534-548. PubMed ID: 28696585
    [Abstract] [Full Text] [Related]

  • 11. Bile acid alterations in nonalcoholic fatty liver disease, obesity, insulin resistance and type 2 diabetes: what do the human studies tell?
    Chávez-Talavera O, Haas J, Grzych G, Tailleux A, Staels B.
    Curr Opin Lipidol; 2019 Jun 26; 30(3):244-254. PubMed ID: 30893108
    [Abstract] [Full Text] [Related]

  • 12. Secondary bile acids improve risk prediction for non-invasive identification of mild liver fibrosis in nonalcoholic fatty liver disease.
    Liu AN, Xu CF, Liu YR, Sun DQ, Jiang L, Tang LJ, Zhu PW, Chen SD, Liu WY, Wang XD, Targher G, Byrne CD, Wong VW, Fu J, Su MM, Loomba R, Zheng MH, Ni Y.
    Aliment Pharmacol Ther; 2023 Apr 26; 57(8):872-885. PubMed ID: 36670060
    [Abstract] [Full Text] [Related]

  • 13. The Potential of Bile Acids as Biomarkers for Metabolic Disorders.
    Yin C, Zhong R, Zhang W, Liu L, Chen L, Zhang H.
    Int J Mol Sci; 2023 Jul 28; 24(15):. PubMed ID: 37569498
    [Abstract] [Full Text] [Related]

  • 14. Bile acids associate with glucose metabolism, but do not predict conversion from impaired fasting glucose to diabetes.
    Chávez-Talavera O, Wargny M, Pichelin M, Descat A, Vallez E, Kouach M, Bigot-Corbel E, Joliveau M, Goossens JF, Le May C, Hadjadj S, Hanf R, Tailleux A, Staels B, Cariou B.
    Metabolism; 2020 Feb 28; 103():154042. PubMed ID: 31785259
    [Abstract] [Full Text] [Related]

  • 15. Bile Acid Alterations Are Associated With Insulin Resistance, but Not With NASH, in Obese Subjects.
    Legry V, Francque S, Haas JT, Verrijken A, Caron S, Chávez-Talavera O, Vallez E, Vonghia L, Dirinck E, Verhaegen A, Kouach M, Lestavel S, Lefebvre P, Van Gaal L, Tailleux A, Paumelle R, Staels B.
    J Clin Endocrinol Metab; 2017 Oct 01; 102(10):3783-3794. PubMed ID: 28938455
    [Abstract] [Full Text] [Related]

  • 16. Hepatocellular Carcinoma in Obesity, Type 2 Diabetes, and NAFLD.
    Reeves HL, Zaki MY, Day CP.
    Dig Dis Sci; 2016 May 01; 61(5):1234-45. PubMed ID: 26921078
    [Abstract] [Full Text] [Related]

  • 17. Serum Bile Acid Levels in Children With Nonalcoholic Fatty Liver Disease.
    Jahnel J, Zöhrer E, Alisi A, Ferrari F, Ceccarelli S, De Vito R, Scharnagl H, Stojakovic T, Fauler G, Trauner M, Nobili V.
    J Pediatr Gastroenterol Nutr; 2015 Jul 01; 61(1):85-90. PubMed ID: 25729888
    [Abstract] [Full Text] [Related]

  • 18. The Associations between Circulating Bile Acids and the Muscle Volume in Patients with Non-alcoholic Fatty Liver Disease (NAFLD).
    Kobayashi Y, Hara N, Sugimoto R, Mifuji-Moroka R, Tanaka H, Eguchi A, Iwasa M, Hasegawa H, Iwata K, Takei Y, Taguchi O.
    Intern Med; 2017 Jul 01; 56(7):755-762. PubMed ID: 28381740
    [Abstract] [Full Text] [Related]

  • 19. Bile Acid Alterations Characterize the Early Onset and Progression of Nonalcoholic Fatty Liver Disease in Young Mice Fed with High Fat and Fructose Diet.
    Xiang W, Liu A, Xu C, Zhang D, Li W, Ni Y.
    Mol Nutr Food Res; 2023 Jun 01; 67(11):e2200636. PubMed ID: 36938649
    [Abstract] [Full Text] [Related]

  • 20. Bile Acid Receptors and the Gut-Liver Axis in Nonalcoholic Fatty Liver Disease.
    Xue R, Su L, Lai S, Wang Y, Zhao D, Fan J, Chen W, Hylemon PB, Zhou H.
    Cells; 2021 Oct 20; 10(11):. PubMed ID: 34831031
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.